Literature DB >> 8302593

Analysis of p53 quaternary structure in relation to sequence-specific DNA binding.

P Hainaut1, A Hall, J Milner.   

Abstract

Quaternary interactions of p53 influence its tertiary structure which, in turn, is critical for sequence-specific DNA binding and tumour suppressor function. Given its regulatory potential we have sought to define the quaternary structure of p53 involved in sequence-specific DNA binding. Double stranded DNA [5'-GGACATGCCCGGGCATGTCC-3'; Funk et al. (1992) Mol. Cell. Biol., 12, 2866-2871] was used to test p53 binding capacity in vitro. The p53 protein was translated in vitro and size fractionated prior to the DNA binding reaction. Two independent DNA binding assays were employed. The first detected electromobility shift of 32P-labelled DNA and was carried out in the presence of PAb421, which stabilises and supershifts p53-DNA complexes. The second detected 35S-labelled p53 bound to biotinylated target DNA in the absence of PAb421. Sequence-specific DNA binding was found to be a property of full length, oligomeric p53. Greatest binding activity involved tetramers and/or higher molecular weight forms of p53, minimal binding was observed for dimers. This size profile was unaffected by PAb421 and it therefore seems unlikely that PAb421 dissociates high molecular weight forms of p53 into dimers. We conclude that high molecular weight forms of p53 are the most effective structures for sequence-specific DNA binding in vitro; these structures may represent tetramers and/or heterogeneous complexes of p53 with other proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302593

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

Authors:  J M Stommel; N D Marchenko; G S Jimenez; U M Moll; T J Hope; G M Wahl
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.

Authors:  Maria Rosario Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

3.  Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a.

Authors:  Han You; Kazuo Yamamoto; Tak Wah Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

4.  Increased activity of p53 in senescing fibroblasts.

Authors:  P Atadja; H Wong; I Garkavtsev; C Veillette; K Riabowol
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

5.  Increased salt concentration reversibly destabilizes p53 quaternary structure and sequence-specific DNA binding.

Authors:  S Butcher; P Hainaut; J Milner
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

6.  Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.

Authors:  E S Stavridi; N H Chehab; L C Caruso; T D Halazonetis
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

7.  Characterization of physical and functional anchor site interactions in human telomerase.

Authors:  Haley D M Wyatt; Deirdre A Lobb; Tara L Beattie
Journal:  Mol Cell Biol       Date:  2007-02-12       Impact factor: 4.272

8.  Molecular dynamics simulation of S100B protein to explore ligand blockage of the interaction with p53 protein.

Authors:  Zhigang Zhou; Yumin Li
Journal:  J Comput Aided Mol Des       Date:  2009-07-14       Impact factor: 3.686

9.  Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation.

Authors:  R Truant; J Antunovic; J Greenblatt; C Prives; J A Cromlish
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

10.  The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding.

Authors:  J L Waterman; J L Shenk; T D Halazonetis
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.